Literature DB >> 25445237

Role of TGF-β signaling pathway on Tenascin C protein upregulation in a pilocarpine seizure model.

Octavio Mercado-Gómez1, Jorge Landgrave-Gómez1, Virginia Arriaga-Avila1, Adriana Nebreda-Corona1, Rosalinda Guevara-Guzmán2.   

Abstract

Seizures have been shown to upregulate the expression of numerous extracellular matrix molecules. Tenascin C (TNC) is an extracellular matrix protein involved in several physiological roles and in pathological conditions. Though TNC upregulation has been described after excitotoxins injection, to date there is no research work on the signal transduction pathway(s) participating in TNC protein overproduction. The aim of this study was to evaluate the role of TGF-β signaling pathway on TNC upregulation. In this study, we used male rats, which were injected with saline or pilocarpine to induce status epilepticus (SE) and killed 24h, 3 and 7 days after pilocarpine administration. For evaluating biochemical changes, we measured protein content of TNC, TGF-β1 and phospho-Smad2/3 for localization of TNC in coronal brain hippocampus at 24h, 3 and 7 days after pilocarpine-caused SE. We found a significant increase of TNC protein content in hippocampal homogenates after 1, 3, and 7 days of pilocarpine-caused SE, together with an enhancement of TNC immunoreactivity in several hippocampal layers and the dentate gyrus field where more dramatic changes occurred. We also observed a significant enhancement of protein content of both the TGF-β1 and the critical downstream transduction effector phospho-Smad2/3 throughout the chronic exposure. Interestingly, animals injected with SB-431542, a TGF-β-type I receptor inhibitor, decreased TNC content in cytosolic fraction and diminished phospho-Smad2/3 content in both cytoplasmic and nuclear fraction compared with pilocarpine vehicle-injected. These findings suggest the participation of TGF-β signaling pathway on upregulation of TNC which in turn support the idea that misregulation of this signaling pathway produces changes that may contribute to disease.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hippocampus; Phospho-Smad2/3; Pilocarpine; Status epilepticus; Tenascin C; Transforming growth factor β

Mesh:

Substances:

Year:  2014        PMID: 25445237     DOI: 10.1016/j.eplepsyres.2014.09.019

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

Review 1.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

2.  TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults.

Authors:  Soo Young Kim; Vladimir V Senatorov; Christapher S Morrissey; Kristina Lippmann; Oscar Vazquez; Dan Z Milikovsky; Feng Gu; Isabel Parada; David A Prince; Albert J Becker; Uwe Heinemann; Alon Friedman; Daniela Kaufer
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

3.  Tgfβ signaling is required for tenocyte recruitment and functional neonatal tendon regeneration.

Authors:  Deepak A Kaji; Kristen L Howell; Zerina Balic; Dirk Hubmacher; Alice H Huang
Journal:  Elife       Date:  2020-06-05       Impact factor: 8.140

4.  In trans variant calling reveals enrichment for compound heterozygous variants in genes involved in neuronal development and growth.

Authors:  Allison J Cox; Fillan Grady; Gabriel Velez; Vinit B Mahajan; Polly J Ferguson; Andrew Kitchen; Benjamin W Darbro; Alexander G Bassuk
Journal:  Genet Res (Camb)       Date:  2019-06-13       Impact factor: 1.588

5.  Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.

Authors:  Tania Aguado; Marta García; Adela García; Gemma Ferrer-Mayorga; Lucía Martínez-Santamaría; Marcela Del Río; Luisa-María Botella; José-María Sánchez-Puelles
Journal:  Cells       Date:  2020-09-16       Impact factor: 6.600

6.  Loss of the Extracellular Matrix Molecule Tenascin-C Leads to Absence of Reactive Gliosis and Promotes Anti-inflammatory Cytokine Expression in an Autoimmune Glaucoma Mouse Model.

Authors:  Susanne Wiemann; Jacqueline Reinhard; Sabrina Reinehr; Zülal Cibir; Stephanie C Joachim; Andreas Faissner
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

7.  Genetic Interaction of H19 and TGFBR1 Polymorphisms with Risk of Epilepsy in a Chinese Population.

Authors:  Zhaoshi Zheng; Yayun Yan; Qi Guo; Libo Wang; Xuemei Han; Songyan Liu
Journal:  Pharmgenomics Pers Med       Date:  2021-01-14

8.  Perineuronal Net Dynamics in the Pathophysiology of Epilepsy.

Authors:  Lata Chaunsali; Bhanu P Tewari; Harald Sontheimer
Journal:  Epilepsy Curr       Date:  2021-05-27       Impact factor: 7.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.